Novo Nordisk presents phase 3 data for next-generation amylin cagrilintide, leading to advancement into dedicated clinical programme US$ 27.05 Min. order: 1 piece ★★★★★ 4.7 (66 reviews) Sold : Login>>
Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes US$ 22.07 Min. order: 1 piece ★★★★★ 4.9 (165 reviews) Sold : Login>>
Taking The BPC-157 & TB-500 WOLVERINE STACK | Thomas Delauer US$ 22.11 Min. order: 1 piece ★★★★★ 4.0 (241 reviews) Sold : Login>>
Novo Nordisk files for FDA approval for CagriSema, the first once-weekly combination of GLP‑1 and amylin analogues US$ 23.01 Min. order: 1 piece ★★★★★ 4.6 (219 reviews) Sold : Login>>